Brian C. Avanzino

Most-cited papers

1. Duplex unwinding and ATPase activities of the DEAD-box helicase eIF4A are coupled by eIF4G and eIF4B

   Ali R. Özeş, K. Feoktistova, Brian C. Avanzino, C. Fraser

   2011Journal of Molecular Biology126 citations Open access

   Semantic Scholar

   Save

2. Cellular cap-binding protein, eIF4E, promotes picornavirus genome restructuring and translation

   Brian C. Avanzino, Gabriele Fuchs, C. Fraser

   2017Proceedings of the National Academy of Sciences of the United States of America56 citations Open access

   Semantic Scholar

   Save

3. Real-time fluorescence assays to monitor duplex unwinding and ATPase activities of helicase proteins

   Ali R. Özeş, K. Feoktistova, Brian C. Avanzino, E. Baldwin +1 more

   2014Nature Protocols48 citations Open access

   Semantic Scholar

   Save

4. A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells

   K. Harris, K. Lorentsen, Harbani K. Malik-Chaudhry, Kaitlyn Loughlin +17 more

   2021Scientific Reports43 citations Open access

   Semantic Scholar

   Save

5. A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer

   Brian C. Avanzino, K. Prabhakar, Pranjali Dalvi, Sharon Hartstein +21 more

   2022Oncoimmunology19 citations Open access

   Semantic Scholar

   Save

6. Molecular mechanism of poliovirus Sabin vaccine strain attenuation

   Brian C. Avanzino, Helen Jue, Clare M. Miller, E. Cheung +2 more

   2018Journal of Biological Chemistry18 citations Open access

   Semantic Scholar

   Save

7. Abstract 4956: Functional characterization of the ivosidenib (AG-120) and azacitidine combination in a mutant IDH1 AML cell model

   K. Yen, V. Chopra, E. Tobin, Brian C. Avanzino +3 more

   2018Experimental and Molecular Therapeutics15 citations

   Semantic Scholar

   Save

8. Combination of azacitidine and enasidenib enhances leukemic cell differentiation and cooperatively hypomethylates DNA.

   Kyle J. Macbeth, V. Chopra, Lin Tang, B. Zheng +6 more

   2021Experimental Hematology14 citations Open access

   Semantic Scholar

   Save

9. Abstract 2280: Functional characterization of combining epigenetic modifiers azacitidine and AG-221 in the TF-1:IDH2R140Q AML model

   V. Chopra, Brian C. Avanzino, K. Mavrommatis, A. Olshen +2 more

   20167 citations

   Semantic Scholar

   Save

10. Serum proteomics expands on identifying more high-affinity antibodies in immunized rabbits than deep B-cell repertoire sequencing alone

    Stefano Bonissonne, N. Castellana, Thiago Lima, K. Harris +4 more

    20193 citations Open access

    Semantic Scholar

    Save

11. A CD3 x FRα T-cell engaging bispecific antibody for efficient killing of ovarian cancer cells with minimal cytokine release.

    B. Buelow, Brian C. Avanzino, A. Balasubramani, A. Boudreau +14 more

    20201 citations

    Semantic Scholar

    Save

12. A Novel Fully Human Bispecific CD19 x CD3 Antibody That Kills Lymphoma Cells with Minimal Cytokine Secretion

    H. Malik, B. Buelow, Brian C. Avanzino, A. Balasubramani +19 more

    2018Blood1 citations

    Semantic Scholar

    Save

13. Abstract 6244: A T cell engaging bispecific antibody utilizing a bivalent tumor-selective folate receptor alpha binding arm for the treatment of ovarian cancer

    Brian C. Avanzino, K. Prabhakar, Pranjali Dalvi, Sharon Hartstein +19 more

    2022Cancer Research0 citations

    Semantic Scholar

    Save

14. DEAD Box Unwinding Caught in the Act

    Brian C. Avanzino, C. Fraser

    2014Structure0 citations Open access

    Semantic Scholar

    Save